Schedule an Appointment

Set up a meeting with us for health consultations. We are always ready to attend to your health needs.

Click Here

WHAT PRECISELY IS PHARMACOGENETICS?

NIH (National Institute of Health) defines Pharmacogenomics is the study of how genes affect a person’s response to drugs. This relatively new field combines pharmacology (the science of drugs) and genomics (the study of genes and their functions) to develop effective, safe medications and doses that will be tailored to a person’s genetic makeup.

BENEFITS OF PHARMACOGENETIC TESTING

  • Patient outcomes are optimal for precise care.
  • Treatment plans are tailored based on results from client’s own genetics.
  • Detect and prevent potential side effects of medications for patients.
  • Medication prescribing trial and error process reduction for patients.
  • Patient will respond a to specific drug regimen from the genetic results.
  • Exclusive drug metabolizing capability will be determined based on a patient’s own.
  • Care planning with long term goals will be achieved.
  • Drug regimen designed with a greater probability of a definite outcome.
  • Recommendations of proper dosages and/or alternatives for optimal treatment.
  • Financial benefits for the patient and time will show its value.
  • Reduction of treatment failures for polypharmacy patients will be eradicated.
  • Physicians prescribing with more confidence will enhance with evidence-based results.
  • Medicare and health insurance spending will become nonexistent.

doctor hand taking a blood sample tube from a rack with machines of analysis in the lab background

WHAT ARE THE POSSIBLE TEST RESULTS?

test result concept
  • Extensive (normal) Metabolizer
  • Intermediate Metabolizer
  • Poor Metabolizer
  • Extensive (normal) Metabolizer
  • Ultra-rapid Metabolizer

WHAT DOES ALL OF THIS MEAN TO THE PATIENT?

  • Every patients body system will not respond in the same way to every medication.
  • Every medication functions differently in every patient’s body.
  • Dosing for patients may change from patient to patient.

PATIENTS AT RISK

  • Polypharmacy (Too many prescription medications)
  • Pain Management
  • Psychiatric disorders
  • Heart Disease
  • Cardiology
  • Cancer